Pharmaceutical manufacturer for Ibuprofen

Dr. Reddy’s Laboratories Ltd. functions as an integrated pharmaceutical firm, dedicated to supplying cost-effective and innovative medications to promote healthier lifestyles. With a focus on Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products, Dr. Reddy’s delivers a range of products and services such as APIs, customized pharmaceutical services, generics, biosimilars, and distinct formulations. The primary therapeutic areas of concentration encompass gastro-intestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s has a presence in various global markets, with significant engagements in the USA, Europe, India, Russia, and other CIS nations.

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 80 billion doses of nearly 8,000 products annually. Its rapidly growing expert workforce exceeds 18,000, including more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, Catalent, Inc. (NYSE:CTLT), is in S&P 500® company, and generated nearly $5 billion in revenue in its 2022 fiscal year.

Granules India Limited is a rapidly expanding pharmaceutical company with top-notch amenities for APIs, PFIs and Finished Dosages, catering to clients in more than 60 nations. We are dedicated to upholding high standards in production, excellence and client relations. Our main office is situated in Hyderabad, and we also have branches in the United States, United Kingdom, Colombia and China, as well as production facilities in India and China.

SMS Lifesciences India Limited, headquartered in Hyderabad, India, is a research-driven company with over three decades of experience. It is a public listed leading API manufacturer, supplying to major generic and innovator firms. With a focus on APIs, the company operates four state-of-the-art facilities and provides quality alternative manufacturing solutions to multinational companies for their contract research and manufacturing needs. The company has multiple manufacturing facilities supporting a wide range and capacity of APIs and Intermediates.

Solara is an API manufacturer focused on research and customer satisfaction, operating in over 75 countries. They specialize in producing APIs for niche therapeutic categories, including complex products like polymer-based APIs and injectable APIs. The company has a team of experienced scientists supported by 6 manufacturing facilities and 2 R&D centers. Additionally, Solara offers Contract Research and Manufacturing Services (CRAMS) from discovery to late phase commercial manufacturing. Solara Active Pharma Sciences, with roots in Strides Shasun Ltd. and Sequent Scientific Ltd., is committed to providing value-based products while prioritizing customer needs. The company has 140+ scientists working at 2 R&D centers and 4 API manufacturing facilities, all with global approvals and 2 dedicated R&D facilities.

We are a Pharmaceutical Company aligned across two business verticals viz. Products and Services. Our Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.

Dipharma is a global Contract Development and Manufacturing Organisation (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients, with more than 500 employees, 4 cGMP plants and commercial offices in Italy, U.S.A. and China. We put our heart and soul into supporting our customers with a competitive and highly proactive approach, backed by 75 years of experience in safely handling hazardous chemical processes using state-of-the-art technologies. As a third-generation family-owned company, we have a long history of stability, commitment and financial solidity. We know how to deliver on creative innovation and we understand the critical importance of matching timelines, while operating in full respect of international regulations, Intellectual Property and third-party patents.

MNK’s Specialty Generics division provides a wide variety of high-quality generic medications, focusing on pain relief, addiction treatment, and ADHD, as well as a comprehensive range of active pharmaceutical ingredients (APIs), such as acetaminophen/paracetamol, DEA scheduled compounds, and stearates. We run the largest API facility in the United States. Discover the range of excipients available from Mallinckrodt Pharmaceuticals for use in pharmaceutical drug delivery systems (DDS).

Founded in 1997 and headquartered in Zhuhai, China, our company is dedicated to the development, manufacturing, and promotion of cost-effective, high-quality generic drugs and API. Our product line focuses on the fundamental therapeutic areas of Cardiovascular, Gastrointestinal, and CNS. We have been acknowledged for our compliance with cGMP and ICH guidelines by regulatory authorities such as NMPA, USFDA, PMDA, and MFDS (Korea). Zhuhai Rundu Pharmaceutical Co., Ltd. is a contemporary scientific and technological pharmaceutical enterprise that integrates drug research and development, production, and distribution. Situated in Jinwan District, Zhuhai City, Guangdong Province, it was established in 1999 and became publicly listed on the Shenzhen Stock Exchange on January 5, 2018 (stock abbreviation: Rundu; stock code: 002923). The company's primary operations revolve around the research and development, production, and sales of chemical-pharmaceutical preparations, chemical raw materials, and pharmaceutical intermediates.

SMS Lifesciences is a prominent participant in APIs/Intermediates production with a robust research and manufacturing team supported by cutting-edge facilities. Originating as a single-facility, single-product manufacturer in 1990, it has expanded into a multi-location group with products spanning various therapeutic segments. In 1997-98, SMS Group was accorded the export house status. Currently, SMS Lifesciences is a publicly listed company with a continuously expanding international and domestic customer base.

Zim offers innovative solutions for administering medications, focusing on enhancing patient convenience and compliance. The company utilizes its own advanced technologies, such as modified release and taste masking, to create and produce distinct pharmaceutical products. Their range includes oral solid dosage formulations and pre-formulations (PFI), encompassing tablets, capsules, dry syrups, pellets, granules, and orally disintegrating strips (ODS). Additionally, they provide services for site transfer/variation for sustained release tablets, oral disintegrating tablets, fast disintegrating capsules, and more.

Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. Wanbury’s major trust area lies in Active Pharmaceutical Ingredient (API) Sales & Marketing in over 50 countries and Pan-India Formulation presence.

HELM AG, a company based in Hamburg and owned by a family, has a 120-year history in 4 diverse sectors: Pharmaceuticals, Chemicals, Crop Protection, and Crop Nutrition. With a global presence through subsidiaries, sales offices, and partnerships, HELM is recognized as one of the world's leading independent marketing firms for chemicals. At HELM Pharma, our goal is to establish ourselves as the top B2B project and marketing platform, offering a distinctive partnership experience. In the marketing of our products, we deliver a comprehensive range of services for our business associates.

To help you reach your next business goal, we live our values in everything we do, provide premium service at every step, and always put people first. Putting people first at every step, IOL Chemicals and Pharmaceuticals Limited is a purpose and service-driven Active Pharma Ingredients (API) Products, Intermediates and Specialty Chemicals Company. Driven by principles of excellence, successful innovation and global leadership, IOL Chemicals and Pharmaceuticals Limited is one of the best pharmaceuticals and specialty chemical companies across the globe built on a prolific history of progress and expansion over three decades. Built on a strong foundation of trust, reliability, vision, and partnership, we galvanize our workers into thinking bigger and aiming higher. Our expanding product portfolio will provide a hands-on, realistic solution to today’s healthcare problems. Today, IOL Chemicals and Pharmaceuticals Limited as emerged as the best pharma API manufacturing company because we invest in people, experience and passion.

Adare Pharma Solutions is a global technology-driven CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical industry. Adare’s specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactured more than 65 products sold by customers in more than 100 countries globally.

Since our inception in 2006, Titan Laboratories has focused on formulating new-age solutions in diversified spectrums of Pellets, Granules, Tablets and Capsule manufacturing. With the expertise of such widespread specialties, we at Titan Laboratories take great pride in our proficiency in providing Quality Analytical Services that focus on the formulation & packaging of both solid and semi-solid finished products. Backed by our holistic approach towards catering to multifarious integrated services, we aim to meet the concept-to-commercialization needs of our customers while providing quality pellets, granules or finish formulations.

Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, NC, is a global specialty chemicals company with dominant positions in lithium, bromine, and refining catalysts. We empower the potential of businesses in numerous critical industries worldwide, ranging from energy and telecommunications to transportation and electronics

The ACIC Group operates as a comprehensive pharmaceutical and fine chemical company, producing and supplying active pharmaceutical ingredients, offering contract manufacturing services, process development, regulatory services, clinical services, and finished dosage forms from cGMP and FDA inspected facilities. Its proven track record and dedication make it an excellent choice for pharmaceutical projects, with the ability to anticipate market and regulatory trends in regulated and semi-regulated markets. The ACIC service relationship is designed to be adaptable to individual needs, allowing for full customization. Additionally, ACIC offers multilingual communication and translation services in French, German, Spanish, Italian, Portuguese, Mandarin, and other languages. ACIC's Open World Service aims to provide more efficient solutions by offering a wider range of global choices, supporting clients in the transition from molecule to market. The company provides solutions in areas such as fine chemicals, marketing and sales, process research, formulation, site transfer, CRO services, electronic CTD format, sales and acquisition of facilities, process development, pilot scale-up, process optimization, manufacturing scale-up, production validation, global regulatory submission, regulatory interpretation, and patent application.

Hubei Biocause Group is a public listed company, involves Pharmaceutical, Chemical and new energy fuel. The company is also the biggest share holder of two insurance companies (Life Insurance and Motor Insurance).Biocause’s pharmaceutical part involves Contract Research, Contract Manufacture and production of API, intermediates and formulations, including tablets, granules, capsules and etc.Biocause is one leading pharmaceutical producer and exporter in China, with strong Production, R&D and Quality system. The company has 8 APIs registered in FDA and 4 APIs with CEP. The company has passed US FDA inspections, EU GMP inspection all on first attempts, covering 3 API facilities and multi-APIs, including kilo production site as well as hundreds tons commercial site. The product has been exported to over 85 countries globally and half of them sold into regulatory market as USA and EU.